[HTML] frontiersin.org

[HTML][HTML] Tackle epithelial-mesenchymal transition with epigenetic drugs in cancer

B Dong, Z Qiu, Y Wu - Frontiers in Pharmacology, 2020 - frontiersin.org
Epithelial-mesenchymal Transition (EMT) is a de-differentiation process in which epithelial
cells lose their epithelial properties to acquire mesenchymal features. EMT is essential for …
被引用次数：23 相关文章

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer.

B Dong, Z Qiu, Y Wu - Frontiers in Pharmacology, 2020 - europepmc.org
Epithelial-mesenchymal Transition (EMT) is a de-differentiation process in which epithelial
cells lose their epithelial properties to acquire mesenchymal features. EMT is essential for …

Tackle Epithelial-Mesenchymal Transition with Epigenetic Drugs in Cancer

B Dong, Z Qiu, Y Wu - uknowledge.uky.edu
Epithelial-mesenchymal Transition (EMT) is a de-differentiation process in which epithelial
cells lose their epithelial properties to acquire mesenchymal features. EMT is essential for …
[HTML] nih.gov

[HTML][HTML] Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer

B Dong, Z Qiu, Y Wu - Frontiers in Pharmacology, 2020 - ncbi.nlm.nih.gov
Epithelial-mesenchymal Transition (EMT) is a de-differentiation process in which epithelial
cells lose their epithelial properties to acquire mesenchymal features. EMT is essential for …

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer

B Dong, Z Qiu, Y Wu - Frontiers in pharmacology, 2020 - pubmed.ncbi.nlm.nih.gov
Epithelial-mesenchymal Transition (EMT) is a de-differentiation process in which epithelial
cells lose their epithelial properties to acquire mesenchymal features. EMT is essential for …